Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Apr 1, 2016 at 12:05 PM EDT

Akari Therapeutics Soars on Positive Preliminary Results

Akari Therapeutics has announced preliminary results from the first paroxysmal nocturnal hemoglobinuria patient treated with subcutaneously administered Coversin.

Chris Lange | Apr 1, 2016 at 9:50 AM EDT

Regeneron Rises on Positive Top-Line Results

Regeneron Pharmaceuticals has announced that two Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic…

Douglas A. McIntyre | Apr 1, 2016 at 6:37 AM EDT

Will Theranos Valuation Go to Zero?

High-tech blood testing company Theranos may be the first big unicorn that has a drop in valuation to zero.

Chris Lange | Mar 31, 2016 at 10:10 AM EDT

Genocea Breaks Out With Very Positive Mid-Stage Results

Genocea Biosciences soared early on Thursday, following the release of positive data from its mid-stage genital herpes clinical trial.

Chris Lange | Mar 30, 2016 at 12:05 PM EDT

Opko Health Stumbles Over FDA Letter

Opko Health saw its shares slide in Wednesday’s regular trading session following the release of a complete response letter from…

Chris Lange | Mar 30, 2016 at 11:55 AM EDT

ContraVir Pharma Falls on Secondary Offering Pricing

ContraVir Pharmaceuticals stock shot up following positive results from a hepatitis B study earlier this week, but now it is…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 30, 2016 at 9:10 AM EDT

Acadia Posts Big Win With FDA Approval

Acadia Pharmaceuticals saw its shares on the rise again this week following an incredibly positive FDA vote on its Parkinson's…

Chris Lange | Mar 29, 2016 at 12:55 PM EDT

SEC Charges Aveo With Misleading Investors

The SEC has announced fraud charges against Aveo Pharmaceuticals and three former executives for misleading investors.

Chris Lange | Mar 29, 2016 at 12:35 PM EDT

ContraVir Pharma Takes Off on Positive Results

ContraVir Pharmaceuticals led the bulls early on Tuesday following the release of positive hepatitis B results.

Chris Lange | Mar 29, 2016 at 12:20 PM EDT

BioPharmX Prices Secondary Offering

BioPharmX saw its shares take a sharp downward turn following the announcement of a secondary offering.

Chris Lange | Mar 29, 2016 at 11:55 AM EDT

Inovio Fails to Impress With HPV Business Update

Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.

Chris Lange | Mar 29, 2016 at 9:35 AM EDT

8 Major Biopharma Events Coming Later in 2016 and in 2017

FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in…

Chris Lange | Mar 28, 2016 at 11:35 AM EDT

Why Merrill Lynch Sees Acadia Rising Another 60%

Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) surged early on Monday morning. This company is under the spotlight by the U.S.…

Chris Lange | Mar 28, 2016 at 10:55 AM EDT

Apricus Bio Top-Line Results Don’t Stand Up to Expectations

Apricus Biosciences announced top-line results from the Phase 2b proof-of-concept study of fispemifene in men with secondary hypogonadism and sexual…

1 … 216 217 218 219 220 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Akari Therapeutics Soars on Positive Preliminary Results

Regeneron Rises on Positive Top-Line Results

Will Theranos Valuation Go to Zero?

Genocea Breaks Out With Very Positive Mid-Stage Results

Opko Health Stumbles Over FDA Letter

ContraVir Pharma Falls on Secondary Offering Pricing

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Acadia Posts Big Win With FDA Approval

SEC Charges Aveo With Misleading Investors

ContraVir Pharma Takes Off on Positive Results

BioPharmX Prices Secondary Offering

Inovio Fails to Impress With HPV Business Update

8 Major Biopharma Events Coming Later in 2016 and in 2017

Why Merrill Lynch Sees Acadia Rising Another 60%

Apricus Bio Top-Line Results Don’t Stand Up to Expectations

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

Akari Therapeutics Soars on Positive Preliminary Results

Regeneron Rises on Positive Top-Line Results

Will Theranos Valuation Go to Zero?

Genocea Breaks Out With Very Positive Mid-Stage Results

Opko Health Stumbles Over FDA Letter

ContraVir Pharma Falls on Secondary Offering Pricing

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Acadia Posts Big Win With FDA Approval

SEC Charges Aveo With Misleading Investors

ContraVir Pharma Takes Off on Positive Results

BioPharmX Prices Secondary Offering

Inovio Fails to Impress With HPV Business Update

8 Major Biopharma Events Coming Later in 2016 and in 2017

Why Merrill Lynch Sees Acadia Rising Another 60%

Apricus Bio Top-Line Results Don’t Stand Up to Expectations

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income